This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
WINREVAIR is a breakthrough biologic for this rare, progressive disease
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Launch of Indian public health standards for Ayush healthcare facilities
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Subscribe To Our Newsletter & Stay Updated
